A-chain of insulin is a hot-spot for CD4⁺ T cell epitopes in human type 1 diabetes
Type 1 diabetes (T1D) is caused by T cell-mediated destruction of the pancreatic insulin-producing β cells. While the role of CD4⁺ T cells in the pathogenesis of T1D is accepted widely, the epitopes recognized by pathogenic human CD4⁺ T cells remain poorly defined. None the less, responses to the N-...
Saved in:
Published in | Clinical and experimental immunology Vol. 156; no. 2; pp. 226 - 231 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Oxford, UK : Blackwell Publishing Ltd
01.05.2009
Blackwell Publishing Ltd Blackwell Blackwell Science Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Type 1 diabetes (T1D) is caused by T cell-mediated destruction of the pancreatic insulin-producing β cells. While the role of CD4⁺ T cells in the pathogenesis of T1D is accepted widely, the epitopes recognized by pathogenic human CD4⁺ T cells remain poorly defined. None the less, responses to the N-terminal region of the insulin A-chain have been described. Human CD4⁺ T cells from the pancreatic lymph nodes of subjects with T1D respond to the first 15 amino acids of the insulin A-chain. We identified a human leucocyte antigen-DR4-restricted epitope comprising the first 13 amino acids of the insulin A-chain (A1-13), dependent upon generation of a vicinal disulphide bond between adjacent cysteines (A6-A7). Here we describe the analysis of a CD4⁺ T cell clone, isolated from a subject with T1D, which recognizes a new HLR-DR4-restricted epitope (KRGIVEQCCTSICS) that overlaps the insulin A1-13 epitope. This is a novel epitope, because the clone responds to proinsulin but not to insulin, T cell recognition requires the last two residues of the C-peptide (Lys, Arg) and recognition does not depend upon a vicinal disulphide bond between the A6 and A7 cysteines. The finding of a further CD4⁺ T cell epitope in the N-terminal A-chain region of human insulin underscores the importance of this region as a target of CD4⁺ T cell responses in human T1D. |
---|---|
Bibliography: | http://dx.doi.org/10.1111/j.1365-2249.2009.03907.x Current address: St Vincent's Institute, The University of Melbourne Department of Medicine, St Vincent's Hospital, 9 Princes Street, Fitzroy, Victoria, Australia. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0009-9104 1365-2249 |
DOI: | 10.1111/j.1365-2249.2009.03907.x |